In this regard, indirect evidence has shown that in genetically modified superoxide dismutase type 1 (SOD1) mice, which are the only ALS mouse model currently used, there was an increase in the peripheral canonical PGC1α system, while specific PGC1α isoforms were reduced in the CNS [267]. The gene discussed is PPARGC1A; the disease is amyotrophic lateral sclerosis.